tiprankstipranks
Advertisement
Advertisement

Inhibrx reports Q1 EPS ($2.15) vs. ($2.80) last year

As of March 31, 2026, the company had cash and cash equivalents of $161.7M, as compared to $124.2M as of December 31, 2025.

Claim 55% Off TipRanks

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1